Mirtazapine (Remeron) - Off-Label for Menopausal Sleep and Appetite Issues

About

Mirtazapine is an atypical antidepressant FDA-approved for major depressive disorder but sometimes prescribed off-label for managing sleep disturbances and appetite/weight loss in menopausal women, due to its sedating effects and potential to stimulate appetite.

Efficacy

Limited clinical trial data specific to menopause; observational evidence suggests improvement in sleep quality and appetite stimulation

Targets Symptoms